MBNL3
Muscleblind-like protein 3
Also known as: CHCR, FLJ11316, MBLX39, MBNL3_HUMAN, MBXL
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NUK0
- Gene
- MBNL3
- Ensembl
- ENSG00000076770
- Chromosome
- X
- Canonical length
- 354 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene encodes a member of the muscleblind-like family of proteins. The encoded protein may function in regulation of alternative splicing and may play a role in the pathophysiology of myotonic dystrophy. Alternatively spliced transcript variants have been described. [provided by RefSeq, Dec 2009]
Canonical amino-acid sequenceUniProt
354 residues, UniProt reviewed canonical sequence.
>Q9NUK0|MBNL3
1 MTAVNVALIR DTKWLTLEVC REFQRGTCSR ADADCKFAHP PRVCHVENGR VVACFDSLKG
61 RCTRENCKYL HPPPHLKTQL EINGRNNLIQ QKTAAAMFAQ QMQLMLQNAQ MSSLGSFPMT
121 PSIPANPPMA FNPYIPHPGM GLVPAELVPN TPVLIPGNPP LAMPGAVGPK LMRSDKLEVC
181 REFQRGNCTR GENDCRYAHP TDASMIEASD NTVTICMDYI KGRCSREKCK YFHPPAHLQA
241 RLKAAHHQMN HSAASAMALQ PGTLQLIPKR SALEKPNGAT PVFNPTVFHC QQALTNLQLP
301 QPAFIPAGPI LCMAPASNIV PMMHGATPTT VSAATTPATS VPFAAPTTGN QLKFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MBNL3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.55
- Highest tissue expression
- 154 nTPM
Expression across tissuesHPA
Tissue
- placenta: 154 nTPM
- liver: 55 nTPM
- testis: 39 nTPM
- epididymis: 27 nTPM
- thymus: 12 nTPM
- tonsil: 12 nTPM
Single-cell type
- cytotrophoblasts: 473 nCPM
- syncytiotrophoblasts: 448 nCPM
- migrating cytotrophoblasts: 238 nCPM
- sertoli cells: 202 nCPM
- hepatocytes: 147 nCPM
- cardiomyocytes: 140 nCPM
Immune cell
- naive B-cell: 23 nTPM
- memory B-cell: 19 nTPM
- non-classical monocyte: 18 nTPM
- plasmacytoid DC: 16 nTPM
- gdT-cell: 16 nTPM
- NK-cell: 16 nTPM
Brain region
- hypothalamus: 12 nTPM
- white matter: 9.2 nTPM
- medulla oblongata: 9 nTPM
- midbrain: 8.2 nTPM
- pons: 6.9 nTPM
- choroid plexus: 6.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.51
- gnomAD pLI
- 0.69
- gnomAD missense Z
- 1.39
- DepMap mean gene effect
- 0.14
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- mRNA processing
- negative regulation of myoblast differentiation
- regulation of RNA splicing
- RNA splicing
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MBNL3 as an antibody target. Whether an autoantibody or antibody against MBNL3 could matter depends on whether native MBNL3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MBNL3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MBNL3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...